XML 32 R32.htm IDEA: XBRL DOCUMENT v2.4.1.9
Share-Based Compensation (Stock Appreciation Rights Activity) (Details) (Stock Appreciation Rights, USD $)
3 Months Ended
May 02, 2015
Stock Appreciation Rights
 
Number of Underlying Shares Outstanding [Roll Forward]  
Number of Underlying Shares, Beginning Balance at January 31, 2015 8,953,675us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
Number of Underlying Shares, Granted 639,808us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
Number of Underlying Shares, Exercised 0anf_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
Number of Underlying Shares, Forfeited (53,500)us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
Number of Underlying Shares, Ending Balance at May 2, 2015 9,539,983us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
Weighted-Average Exercise Price [Roll Forward]  
Weighted-Average Grant Date Fair Value, Beginning Balance $ 40.28us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
Fair value (in dollars per share) $ 22.44us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
Weighted-Average Exercise Price, Exercised $ 0.00anf_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsExercisedinPeriodWeightedAverageGrantDateFairValue
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
Weighted-Average Exercise Price, Forfeited or expired $ 44.82us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
Weighted-Average Grant Date Fair Value, Ending Balance $ 39.06us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
Aggregate Intrinsic Value, Outstanding $ 1,099,816anf_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAggregateIntrinsicValue
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
Weighted-Average Remaining Contractual Life, Outstanding 2 years 11 months
Number of Underlying shares, Stock appreciation rights exercisable 8,330,684anf_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
Number of Underlying Shares, Stock appreciation rights expected to become exercisable 1,056,983anf_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToBecomeExercisableNumber
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
Weighted-Average Exercise Price, Stock appreciation rights exercisable $ 40.34anf_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
Weighted-Average Exercise Price, Stock appreciation rights expected to become exercisable $ 30.25anf_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToBecomeExercisableWeightedAverageExercisePrice
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
Aggregate Intrinsic Value, Stock appreciation rights exercisable 1,056,000anf_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableIntrinsicValue
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
Aggregate Intrinsic Value, Stock appreciation rights expected to become exercisable $ 36,574anf_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToExercisableIntrinsicValue
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
Weighted-Average Remaining Contractual Life, Stock appreciation rights exercisable 1 year 11 months
Weighted Average Remaining Contractual Life, Stock appreciation rights expected to become exercisable 9 years 4 months